30 related articles for article (PubMed ID: 2995014)
1. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.
Avenell A; Mak JC; O'Connell D
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD000227. PubMed ID: 24729336
[TBL] [Abstract][Full Text] [Related]
2. Treatment of osteoporosis with vitamin D.
Kanis JA; McCloskey EV; de Takats D; Bernard J; Zhang DM
Osteoporos Int; 1997; 7 Suppl 3():S140-6. PubMed ID: 9536320
[No Abstract] [Full Text] [Related]
3. Prevention of bone loss in postmenopausal and senile osteoporosis with vitamin D analogues.
Gallagher JC
Osteoporos Int; 1993; 3 Suppl 1():172-5. PubMed ID: 8461553
[No Abstract] [Full Text] [Related]
4. Treatment of osteoporosis with vitamin D3.
Shiraki M
Osteoporos Int; 1993; 3 Suppl 1():176-80. PubMed ID: 8384903
[No Abstract] [Full Text] [Related]
5. Prevention and treatment of osteopenia in the ovariectomized rat: effect of combined therapy with estrogens, 1-alpha vitamin D, and prednisolone.
Geusens P; Dequeker J; Nijs J; Verstraeten A; Bramm E
Calcif Tissue Int; 1991 Feb; 48(2):127-37. PubMed ID: 2013013
[TBL] [Abstract][Full Text] [Related]
6. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites.
Schömig M; Ritz E
Nephrol Dial Transplant; 2000; 15 Suppl 5():18-24. PubMed ID: 11073270
[TBL] [Abstract][Full Text] [Related]
7. [The effect of 1,25(OH)2D3 on bone mineral content in senile osteoporosis--a dose-finding study].
Shiraki M; Ito H; Orimo H
Nihon Naibunpi Gakkai Zasshi; 1989 Nov; 65(11):1253-63. PubMed ID: 2591609
[TBL] [Abstract][Full Text] [Related]
8. Treatment of secondary hyperparathyroidism with intermittent oral high doses of 1-alpha-OHD3 plus pharmacological dose of 24,25(OH)2D3.
Djukanović L; Pejanović S; Dragojlović Z; Stosović M
Ren Fail; 1994 Nov; 16(6):715-23. PubMed ID: 7899583
[TBL] [Abstract][Full Text] [Related]
9. Circulating 1,25-dihydroxycholecalciferol after intravenous injections of 1 alpha-hydroxycholecalciferol in patients on regular haemodialysis.
Papapoulos SE; vd Berg H; Frölich M; Valentijn RM
Nephrol Dial Transplant; 1988; 3(5):647-50. PubMed ID: 3146722
[TBL] [Abstract][Full Text] [Related]
10. Influence of dietary vitamin D3 on the circulating concentration of its active metabolites in the chick and rat.
Hughes MR; Baylink DJ; Gonnerman WA; Toverud SU; Ramp WK; Haussler MR
Endocrinology; 1977 Mar; 100(3):799-806. PubMed ID: 233823
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3).
Shiraki M; Orimo H; Ito H; Akiguchi I; Nakao J; Takahashi R; Ishizuka S
Endocrinol Jpn; 1985 Apr; 32(2):305-15. PubMed ID: 2995014
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
